EnBio Holdings, Inc.(JP:6092)
Â¥610.00-10.00 (-1.61%)
JP:6092
EnBio Holdings, Inc. financials statements
Â¥610.00
At close:-10.00 (-1.61%)
Want to see JP:6092 full AI Analyst Report?
EnBio Holdings, Inc. (6092) Ratios
0 Followers
EnBio Holdings, Inc. Ratios
JP:6092's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, JP:6092's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.86 | 2.20 | 1.99 | 1.64 | 1.87 |
| Quick Ratio | 1.25 | 1.34 | 1.29 | 0.88 | 1.34 |
| Cash Ratio | 0.68 | 0.78 | 0.87 | 0.63 | 0.69 |
| Solvency Ratio | 0.08 | 0.06 | 0.11 | 0.12 | 0.10 |
| Operating Cash Flow Ratio | 0.00 | 0.23 | 0.40 | 0.44 | 0.70 |
| Short-Term Operating Cash Flow Coverage | 0.01 | 0.40 | 0.70 | 0.63 | 1.26 |
| Net Current Asset Value | ¥ -3.01B | ¥ -2.11B | ¥ -2.47B | ¥ -3.17B | ¥ -3.94B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.47 | 0.45 | 0.51 | 0.52 |
| Debt-to-Equity Ratio | 1.10 | 1.15 | 1.01 | 1.31 | 1.46 |
| Debt-to-Capital Ratio | 0.52 | 0.54 | 0.50 | 0.57 | 0.59 |
| Long-Term Debt-to-Capital Ratio | 0.42 | 0.46 | 0.42 | 0.46 | 0.53 |
| Financial Leverage Ratio | 2.32 | 2.47 | 2.27 | 2.56 | 2.78 |
| Debt Service Coverage Ratio | 0.30 | 0.49 | 0.52 | 0.40 | 0.57 |
| Interest Coverage Ratio | 6.00 | 9.04 | 7.11 | 10.87 | 9.92 |
| Debt to Market Cap | 2.08 | 1.72 | 1.79 | 1.76 | 1.56 |
| Interest Debt Per Share | 1264.39 | 1336.34 | 1094.93 | 1358.37 | 1311.51 |
| Net Debt to EBITDA | 5.06 | 3.06 | 3.10 | 3.45 | 3.97 |
| Profitability Margins | |||||
| Gross Profit Margin | 24.87% | 29.20% | 25.94% | 34.04% | 26.99% |
| EBIT Margin | 7.95% | 12.82% | 12.33% | 16.72% | 13.61% |
| EBITDA Margin | 12.62% | 17.12% | 16.91% | 21.65% | 17.41% |
| Operating Profit Margin | 7.95% | 12.82% | 8.51% | 16.72% | 13.68% |
| Pretax Profit Margin | 6.58% | 7.24% | 11.13% | 15.18% | 12.23% |
| Net Profit Margin | 4.24% | 2.10% | 7.40% | 10.00% | 7.28% |
| Continuous Operations Profit Margin | 3.94% | 2.00% | 7.73% | 9.79% | 7.87% |
| Net Income Per EBT | 64.47% | 28.96% | 66.49% | 65.87% | 59.50% |
| EBT Per EBIT | 82.82% | 56.52% | 130.77% | 90.82% | 89.44% |
| Return on Assets (ROA) | 2.14% | 1.16% | 3.67% | 4.68% | 4.00% |
| Return on Equity (ROE) | 4.95% | 2.87% | 8.34% | 11.96% | 11.11% |
| Return on Capital Employed (ROCE) | 5.18% | 9.16% | 5.37% | 10.54% | 9.51% |
| Return on Invested Capital (ROIC) | 2.56% | 2.17% | 3.22% | 5.46% | 5.32% |
| Return on Tangible Assets | 2.18% | 1.18% | 3.76% | 4.82% | 4.13% |
| Earnings Yield | 9.33% | 4.28% | 14.76% | 16.11% | 11.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.53 | 5.47 | 7.54 | 10.26 | 5.64 |
| Payables Turnover | 10.76 | 7.70 | 7.56 | 13.37 | 10.57 |
| Inventory Turnover | 2.71 | 2.01 | 2.45 | 1.59 | 3.55 |
| Fixed Asset Turnover | 1.21 | 1.44 | 1.21 | 1.16 | 1.14 |
| Asset Turnover | 0.50 | 0.55 | 0.50 | 0.47 | 0.55 |
| Working Capital Turnover Ratio | 2.59 | 2.44 | 2.76 | 2.77 | 2.72 |
| Cash Conversion Cycle | 181.10 | 200.78 | 148.87 | 238.16 | 133.04 |
| Days of Sales Outstanding | 80.55 | 66.73 | 48.42 | 35.58 | 64.71 |
| Days of Inventory Outstanding | 134.46 | 181.44 | 148.71 | 229.89 | 102.85 |
| Days of Payables Outstanding | 33.92 | 47.39 | 48.27 | 27.30 | 34.53 |
| Operating Cycle | 215.01 | 248.17 | 197.13 | 265.46 | 167.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.71 | 143.97 | 208.51 | 299.49 | 363.51 |
| Free Cash Flow Per Share | -177.82 | 14.68 | 73.25 | 124.09 | 187.96 |
| Dividend Paid and CapEx Coverage Ratio | 0.01 | 1.04 | 1.47 | 1.63 | 1.98 |
| Capital Expenditure Coverage Ratio | 0.01 | 1.11 | 1.54 | 1.71 | 2.07 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.11 | 0.19 | 0.22 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.09 | 0.17 | 0.24 | 0.27 |
| Free Cash Flow Yield | -29.69% | 1.92% | 12.17% | 16.35% | 22.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.72 | 23.34 | 6.78 | 6.21 | 8.42 |
| Price-to-Sales (P/S) Ratio | 0.45 | 0.49 | 0.50 | 0.62 | 0.61 |
| Price-to-Book (P/B) Ratio | 0.53 | 0.67 | 0.57 | 0.74 | 0.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.37 | 51.97 | 8.22 | 6.12 | 4.42 |
| Price-to-Operating Cash Flow Ratio | 221.33 | 5.30 | 2.89 | 2.53 | 2.28 |
| Price-to-Earnings Growth (PEG) Ratio | -0.29 | -0.56 | -0.25 | 0.26 | 0.07 |
| Enterprise Value Multiple | 8.66 | 5.92 | 6.06 | 6.32 | 7.49 |
| Enterprise Value | 11.66B | 12.80B | 9.82B | 11.11B | 11.72B |
| EV to EBITDA | 8.66 | 5.92 | 6.06 | 6.32 | 7.49 |
| EV to Sales | 1.09 | 1.01 | 1.03 | 1.37 | 1.30 |
| EV to Free Cash Flow | -8.09 | 107.58 | 16.80 | 13.48 | 9.39 |
| EV to Operating Cash Flow | 531.82 | 10.97 | 5.90 | 5.59 | 4.86 |
| Tangible Book Value Per Share | 1084.77 | 1099.34 | 1017.35 | 955.74 | 817.70 |
| Shareholders’ Equity Per Share | 1128.71 | 1140.92 | 1064.83 | 1022.04 | 886.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.40 | 0.72 | 0.31 | 0.35 | 0.36 |
| Revenue Per Share | 1317.23 | 1558.16 | 1200.31 | 1222.63 | 1353.89 |
| Net Income Per Share | 55.90 | 32.69 | 88.85 | 122.27 | 98.52 |
| Tax Burden | 0.64 | 0.29 | 0.66 | 0.66 | 0.59 |
| Interest Burden | 0.83 | 0.57 | 0.90 | 0.91 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.17 | 0.16 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.05 | 4.40 | 2.35 | 2.45 | 3.69 |
Currency in JPY

